Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Daniela Savi, Francesca Lucca, Gloria Tridello, Ilaria Meneghelli, Isabella Comello, Sara Tomezzoli, Monica Signorini, Elena Proietti, Giulia Cucchetto, Sonia Volpi & Marco Cipolli. (2023) Long-term clinical outcomes of elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis and advanced pulmonary disease. Respiratory Medicine 219, pages 107406.
Crossref
Crossref
Sotirios Fouzas, Christos Kogias, Maria Gioulvanidou, Aris Bertzouanis, Elisavet‐Anna Chrysochoou, Michael Β. Anthracopoulos, John Tsanakas & Elpis Hatziagorou. (2023) Low‐frequency oscillometry indices to assess ventilation inhomogeneity in CF patients. Pediatric Pulmonology 58:11, pages 3147-3155.
Crossref
Crossref
Katarzyna Walicka-Serzysko, Magdalena Postek, Urszula Borawska-Kowalczyk, Justyna Milczewska & Dorota Sands. (2023) Pulmonary Function Tests in the Evaluation of Early Lung Disease in Cystic Fibrosis. Journal of Clinical Medicine 12:14, pages 4735.
Crossref
Crossref
Anastasia Ward, Ramil Mauleon, Jacinta Arellano, Chee Y. Ooi & Nedeljka Rosic. (2023) Critical disease burdens of Australian adults with cystic fibrosis: Results from an online survey. Pediatric Pulmonology 58:7, pages 1931-1941.
Crossref
Crossref
Patrícia David Charro, Lucas Luges Santana, Karla Luciana Magnani Seki, Nilson Moro Junior, João Américo Domingos & Gustavo Christofoletti. (2023) Motor and respiratory functions are main challenges to patients with multiple sclerosis. Fisioterapia em Movimento 36.
Crossref
Crossref
A. Susanne Dittrich, Markus Dumke, Ferdinand Kapl, Philipp Schneider, Sabine Wege, Simon Gräber, Mirjam Stahl, Felix J. Herth, Lutz Naehrlich, Marcus A. Mall & Olaf Sommerburg. (2023) Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany. Respiration 102:5, pages 1-1.
Crossref
Crossref
Nicholas J. Simmonds, C. Kors van der Ent, Carla Colombo, Nils Kinnman, Cynthia DeSouza, Teja Thorat, Marci L. Chew, Keval Chandarana & Carlo Castellani. (2023) VOCAL: An observational study of ivacaftor for people with cystic fibrosis and selected non–G551D-CFTR gating mutations. Journal of Cystic Fibrosis 22:1, pages 124-131.
Crossref
Crossref
Alexander J. Grooms, Benjamin J. Burris & Abraham K. Badu‐Tawiah. (2022) Mass spectrometry for metabolomics analysis: Applications in neonatal and cancer screening. Mass Spectrometry Reviews.
Crossref
Crossref
Suélen Camargo1, Frederico Friedrich2, Marina Puerari Pieta2, Luíza C. S. Martins2 & Leonardo A. Pinto1,2. (2022) Correlation between the Brody score and lung function using an ultra-low-dose CT protocol without anesthesia in children with cystic fibrosis. Jornal Brasileiro de Pneumologia, pages e20220085.
Crossref
Crossref
Clemente J. Britto, Felix Ratjen & John P. Clancy. (2022) Emerging Approaches to Monitor and Modify Care in the era of CFTR Modulators. Clinics in Chest Medicine 43:4, pages 631-646.
Crossref
Crossref
Elpis Hatziagorou, Vasiliki Avramidou, Maria Gioulvanidou, Persefoni Talimtzi, Eleana Kouroukli, Chrysanthi Mantsiou, Ioannis Lialias, Lemonia Nousia & John Tsanakas. (2022) Pulmonary exacerbations, airway pathogens, and long‐term course of lung clearance index in children and young adults with cystic fibrosis. Pediatric Pulmonology 57:12, pages 3069-3076.
Crossref
Crossref
P. Aurora, Julie Anne Duncan, S. Lum, G. Davies, A. Wade, J. Stocks, L. Viviani, E. Raywood, C. Pao, G. Ruiz & A. Bush. (2022) Early Pseudomonas aeruginosa predicts poorer pulmonary function in preschool children with cystic fibrosis. Journal of Cystic Fibrosis 21:6, pages 988-995.
Crossref
Crossref
C. Carpio, M. Lerín, I. Torres, M. Fernández-Velilla, F. García Río, R. Álvarez-Sala & C. Prados. (2022) Factors predicting 6-min walking test indexes in adults with cystic fibrosis. Science & Sports 37:5-6, pages 438-445.
Crossref
Crossref
Elias Aguiar da Silva1, Camila Durante2, Daniele Rossato3,4, Paulo de Tarso Roth Dalcin5 & Bruna Ziegler2. (2022) Variation in lung function and clinical aspects in adults with cystic fibrosis. Jornal Brasileiro de Pneumologia, pages e20220155.
Crossref
Crossref
Robin Caird, Michael Williamson, Azeez Yusuf, Debananda Gogoi, Michelle Casey, Noel G. McElvaney & Emer P. Reeves. (2022) Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease. International Journal of Molecular Sciences 23:12, pages 6400.
Crossref
Crossref
Carla Colombo, Marco Cipolli, Valeria Daccò, Paola Medino, Federico Alghisi, Maura Ambroni, Raffaele Badolato, Fiorella Battistini, Elisabetta Bignamini, Rosaria Casciaro, Fabiana Ciciriello, Mirella Collura, Isabella Comello, Michela Francalanci, Francesca Ficili, Anna Folino, Salvatore Leonardi, Giuseppina Leonetti, Maria Cristina Lucanto, Francesca Lucca, Massimo Maschio, Valeria Mencarini, Barbara Messore, Giovanna Pisi, Giovanna Pizzamiglio, Piercarlo Poli, Valeria Raia, Luca Riberi, Mirco Ros, Novella Rotolo, Angela Sepe, Giovanni Taccetti, Pamela Vitullo & Gianfranco Alicandro. (2021) Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society. Infection 50:3, pages 671-679.
Crossref
Crossref
Aarti Shakkottai, Sanaya Irani, Samya Z. Nasr, Louise M. O'Brien & Ronald D. Chervin. (2022) Risk factors for obstructive sleep apnea in cystic fibrosis. Pediatric Pulmonology 57:4, pages 926-934.
Crossref
Crossref
Jagdev Singh, Susan Towns, Geshani Jayasuriya, Sharon Hunt, Sharon Simonds, Christie Boyton, Anna Middleton, Andrea Kench, Chetan Pandit, Lucy R. Keatley, Jimmy Chien, Jennifer Bishop, Yang Song, Paul Robinson, Hiran Selvadurai, Peter G. Middleton & Dominic A. Fitzgerald. (2022) Transition to adult care in cystic fibrosis: The challenges and the structure. Paediatric Respiratory Reviews 41, pages 23-29.
Crossref
Crossref
Jamie C. Harris, Melanie S. Collins, Pamela H. Huang, Craig M. Schramm, Thomas Nero, Jing Yan & Thomas S. Murray. (2022) Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers. Microbiology Spectrum 10:1.
Crossref
Crossref
Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson & Jeffry Weers. (2022) Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews 74:1, pages 48-118.
Crossref
Crossref
Daan Caudri, Lidija Turkovic, Nicholas H. Klerk, Tim Rosenow, Conor P. Murray, Ewout W. Steyerberg, Sarath C. Ranganathan, Peter Sly, Stephen M. Stick & Oded Breuer. (2021) A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis. Pediatric Pulmonology 57:1, pages 122-131.
Crossref
Crossref
Soontharee Congrete & Mark Metersky. (2021) Telemedicine and Remote Monitoring as an Adjunct to Medical Management of Bronchiectasis. Life 11:11, pages 1196.
Crossref
Crossref
Ioanna Loukou, Maria Moustaki, Agni Deligianni, Olympia Sardeli & Konstantinos Douros. (2021) Forced Oscillation Technique for Monitoring the Respiratory Status of Children with Cystic Fibrosis: A Systematic Review. Children 8:10, pages 857.
Crossref
Crossref
Elpis Hatziagorou, Asterios Kampouras, Vasiliki Avramidou, Ilektra Toulia, Elisavet-Anna Chrysochoou, Maria Galogavrou, Fotios Kirvassilis & John Tsanakas. (2021) Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing. Frontiers in Pediatrics 9.
Crossref
Crossref
Neeraj Vij. (2021) Prognosis-Based Early Intervention Strategies to Resolve Exacerbation and Progressive Lung Function Decline in Cystic Fibrosis. Journal of Personalized Medicine 11:2, pages 96.
Crossref
Crossref
Aarti Shakkottai, Ronald D. Chervin, Samya Z. Nasr & Louise M. O’Brien. 2021. Pediatric Sleep Medicine. Pediatric Sleep Medicine
543
553
.
Sivagurunathan Sutharsan, Susanne Naehrig, Uwe Mellies, Christian Sieder & Jörg Ziegler. (2020) An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Arul Earnest, Farhad Salimi, Claire E. Wainwright, Scott C. Bell, Rasa Ruseckaite, Tom Ranger, Tom Kotsimbos & Susannah Ahern. (2020) Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry. Scientific Reports 10:1.
Crossref
Crossref
Aarti Shakkottai, Samya Z. Nasr, Fauziya Hassan, Sanaya Irani, Louise M. O'Brien & Ronald D. Chervin. (2020) Sleep-disordered breathing in cystic fibrosis. Sleep Medicine 74, pages 57-65.
Crossref
Crossref
David ParsonsMartin Donnelley. (2020) Will Airway Gene Therapy for Cystic Fibrosis Improve Lung Function? New Imaging Technologies Can Help Us Find Out. Human Gene Therapy 31:17-18, pages 973-984.
Crossref
Crossref
Zsolt Bene, Zsolt Fejes, Milan MacekJr.Jr., Margarida D. Amaral, István Balogh & Béla NagyJr.Jr.. (2020) Laboratory biomarkers for lung disease severity and progression in cystic fibrosis. Clinica Chimica Acta 508, pages 277-286.
Crossref
Crossref
Scott C Bell, Marcus A Mall, Hector Gutierrez, Milan Macek, Susan Madge, Jane C Davies, Pierre-Régis Burgel, Elizabeth Tullis, Claudio Castaños, Carlo Castellani, Catherine A Byrnes, Fiona Cathcart, Sanjay H Chotirmall, Rebecca Cosgriff, Irmgard Eichler, Isabelle Fajac, Christopher H Goss, Pavel Drevinek, Philip M Farrell, Anna M Gravelle, Trudy Havermans, Nicole Mayer-Hamblett, Nataliya Kashirskaya, Eitan Kerem, Joseph L Mathew, Edward F McKone, Lutz Naehrlich, Samya Z Nasr, Gabriela R Oates, Ciaran O'Neill, Ulrike Pypops, Karen S Raraigh, Steven M Rowe, Kevin W Southern, Sheila Sivam, Anne L Stephenson, Marco Zampoli & Felix Ratjen. (2020) The future of cystic fibrosis care: a global perspective. The Lancet Respiratory Medicine 8:1, pages 65-124.
Crossref
Crossref